|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0026914,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0199176,
umls-concept:C0243009,
umls-concept:C0442805,
umls-concept:C0457454,
umls-concept:C0871489,
umls-concept:C1318970,
umls-concept:C1444662,
umls-concept:C2603343
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2000-10-5
|
|
pubmed:abstractText |
Patients infected with HIV who experience increases in CD4(+) cell counts are at reduced risk for opportunistic infections. However, the safety of discontinuing prophylaxis against Mycobacterium avium complex has been uncertain.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0003-4819
|
|
pubmed:author |
pubmed-author:AbergJ AJA,
pubmed-author:BassilyE LEL,
pubmed-author:BensonC ACA,
pubmed-author:CohnS ESE,
pubmed-author:CurrierJ SJS,
pubmed-author:HafnerRR,
pubmed-author:HealdA EAE,
pubmed-author:KnirschCC,
pubmed-author:KoletarS LSL,
pubmed-author:LedermanH MHM,
pubmed-author:McCutchanJ AJA,
pubmed-author:MurphyR LRL,
pubmed-author:ValdezHH,
pubmed-author:WilliamsP LPL
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
3
|
|
pubmed:volume |
133
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
493-503
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11015162-AIDS-Related Opportunistic Infections,
pubmed-meshheading:11015162-Adult,
pubmed-meshheading:11015162-Anti-Bacterial Agents,
pubmed-meshheading:11015162-Anti-HIV Agents,
pubmed-meshheading:11015162-Azithromycin,
pubmed-meshheading:11015162-CD4 Lymphocyte Count,
pubmed-meshheading:11015162-Disease Progression,
pubmed-meshheading:11015162-Double-Blind Method,
pubmed-meshheading:11015162-Female,
pubmed-meshheading:11015162-HIV Infections,
pubmed-meshheading:11015162-HIV-1,
pubmed-meshheading:11015162-Humans,
pubmed-meshheading:11015162-Immunocompromised Host,
pubmed-meshheading:11015162-Male,
pubmed-meshheading:11015162-Mycobacterium avium Complex,
pubmed-meshheading:11015162-Mycobacterium avium-intracellulare Infection,
pubmed-meshheading:11015162-Placebos,
pubmed-meshheading:11015162-Proportional Hazards Models,
pubmed-meshheading:11015162-RNA, Viral,
pubmed-meshheading:11015162-Viral Load
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.
|
|
pubmed:affiliation |
University of California, Los Angeles, CARE Center, 10833 LeConte Avenue, Room BH-412 CHS, Los Angeles, CA 90095, USA. jscurrier@mednet.ucla.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
